Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
24%
ALSO IN MEDX
MEDX
28
HOLDINGS
43%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.2% | 8.8% | 7.2% |
|
BRISTOL-MYERS SQUIBB CO | 6.1% | 5.0% | 5.0% |
|
JOHNSON & JOHNSON | 7.4% | 4.7% | 4.7% |
|
PFIZER INC | 7.6% | 4.0% | 4.0% |
|
AMGEN INC | 3.7% | 5.9% | 3.7% |
FTXH Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 3.7% |
|
MERCK & CO. INC. | 3.7% |
|
VIATRIS, INC. | 3.7% |
|
ZOETIS INC | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.6% |
|
PFIZER INC | 3.6% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
JOHNSON & JOHNSON | 2.7% |
|
EXELIXIS INC | 2.4% |
|
ELANCO ANIMAL HEALTH, INC. | 2.4% |
FTXH Underweight Relative to MEDX
|
ELI LILLY & CO | -12.6% |
 |
NOVARTIS AG-ADR | -6.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.3% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
|
CRISPR THERAPEUTICS AG | -3.6% |
|
ALKERMES PLC | -3.1% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% |
|
AMGEN INC | -2.2% |
|
ABBVIE INC | -1.7% |